| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/19/2000 | EP0993457A1 Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists |
| 04/19/2000 | EP0993456A1 2-substituted 4,5-diaryl imidazoles |
| 04/19/2000 | EP0993455A1 POLYMORPHS OF 8-CHLORO-6, 11-DIHYDRO-11- (4-PIPERIDYLIDENE) -5H-BENZO 5,6] CYCLOHEPTA 1,2-b]PYRIDINE |
| 04/19/2000 | EP0993454A1 Benzo(5,6)cyclohepta(1,2b)pyridine derivatives useful for inhibition of farnesyl protein transferase |
| 04/19/2000 | EP0993452A1 Angiogenesis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives |
| 04/19/2000 | EP0993450A1 New compounds |
| 04/19/2000 | EP0993449A1 Quinoline derivatives as pde iv and/or tnf inhibitors |
| 04/19/2000 | EP0993446A1 Process for preparing nifedipine |
| 04/19/2000 | EP0993442A1 Hydrazine derivatives |
| 04/19/2000 | EP0993439A1 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as mek inhibitors |
| 04/19/2000 | EP0993437A1 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as mek inhibitors |
| 04/19/2000 | EP0993436A1 (S) 2-METHYLAMINO-2-PHENYL-$i(n)-BUTYL 3,4,5-TRIMETHOXYBENZOATE, ITS APPLICATION TO THE TREATMENT OF CHRONIC PAIN |
| 04/19/2000 | EP0993433A1 Method for producing calcium pyruvates |
| 04/19/2000 | EP0993305A2 Composition for enhanced uptake of polar drugs from mucosal surfaces |
| 04/19/2000 | EP0993304A1 Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroxamic acid derivative |
| 04/19/2000 | EP0993301A1 Cocaine receptor binding ligands |
| 04/19/2000 | EP0993300A1 Antithrombotic agents |
| 04/19/2000 | EP0993299A1 N-oxides of heterocyclic esters, amides, thioesters, and ketones |
| 04/19/2000 | EP0993297A1 Dilating and support apparatus with disease inhibitors and methods for use |
| 04/19/2000 | EP0881897A4 Composition and method for effecting superficial chemical skin peels |
| 04/19/2000 | EP0880524B1 Adenosin antagonists, method of preparing them and their use as drugs |
| 04/19/2000 | EP0862438B1 sphingosylphosphorylcholine as a wound-healing agent |
| 04/19/2000 | EP0769950A4 Method and compound for the treatment of hair loss |
| 04/19/2000 | EP0741565B1 Process for producing s(+)-ibuprofen particles |
| 04/19/2000 | EP0738262B1 Novel heterocyclic compounds |
| 04/19/2000 | EP0713487B1 Novel quinolone carboxylic acid derivatives |
| 04/19/2000 | EP0711297B1 Rapamycin derivative with antimicrobial, anticancer and immunomodulation activity |
| 04/19/2000 | EP0686144B1 New compounds |
| 04/19/2000 | EP0666862B1 6-(substituted methylene) penems and intermediates |
| 04/19/2000 | EP0586520B1 Backbone modified oligonucleotide analogs |
| 04/19/2000 | CN1251129A Use of antibacterial active substance triclocarbance in liquid soaps |
| 04/19/2000 | CN1251112A Cross-linked vinyl polymers with bile acid adsorbing effect |
| 04/19/2000 | CN1251105A 2,3-dihydrofuro [3,2-b] pyridin, prepn. and application thereof of therapy |
| 04/19/2000 | CN1251102A Tetrahydropyrido compounds |
| 04/19/2000 | CN1251101A Salt of naphthyridine carobxylic acide derivative |
| 04/19/2000 | CN1251100A Method for making arylamino triazolopyridines |
| 04/19/2000 | CN1251099A Thiazole benzenesulfonamides as beta 3 agoniste for treatment of diabetes and obesity |
| 04/19/2000 | CN1251098A Pyrrole compounds, their prodn. and their use |
| 04/19/2000 | CN1251097A Phthalazines with angiogenesis inhibiting activity |
| 04/19/2000 | CN1251093A Process for producing optically active imidazole compound, intermediates for synthesizing same |
| 04/19/2000 | CN1251092A Certain cyclic thio substitued acylaminoacid amide derivatives |
| 04/19/2000 | CN1251091A New compound |
| 04/19/2000 | CN1251045A Gel delivery vehicles for anticellular proliferative agent |
| 04/19/2000 | CN1251042A Identification of broadly reactive DR restricted epitopes |
| 04/19/2000 | CN1251040A Endothelin antagonist |
| 04/19/2000 | CN1251039A Antitussive compositions |
| 04/19/2000 | CN1251038A IL-8 receptor antagonists |
| 04/19/2000 | CN1251037A Triaryl methane compounds for sickle cell disease |
| 04/19/2000 | CN1251035A Gastrointestinal mucosa-adherent pharmaceutical composition |
| 04/19/2000 | CN1251021A 宠物食品组合物 Pet food composition |
| 04/19/2000 | CN1250777A 5,10-dihydrodi pyridino [2,3-b: 2,3-e] pyrazine and 5,10 dihydrodipyridino [2,3-b:3,2-3] pyrazine compound, and prepn.therefor |
| 04/19/2000 | CN1250776A Heterodicyclic compound derivatives |
| 04/19/2000 | CN1250771A Novel cyclocompound having cycloalkylene chain, prepn. method and pharmaceutical compositions contg. same |
| 04/19/2000 | CN1250653A Oral liquid prepared from water-soluble chitinous amine |
| 04/19/2000 | CN1250652A Compositions contg. benzoxazinone and nucleoside like materials |
| 04/19/2000 | CN1250651A Medicinal composition for preventing and curing intracranial hypertension |
| 04/19/2000 | CN1250617A Process for preparing additive rich in organic iodine compound from plant |
| 04/19/2000 | CN1051560C Method for preparing chelate of antibiotic and complex metallic salt |
| 04/19/2000 | CN1051559C Novel aminooligosaccharide derivative and process for preparing same |
| 04/19/2000 | CN1051558C Anthracyclie derivatives, prepn. method and use thereof |
| 04/19/2000 | CN1051551C Novel pyrrolocarbazoles derivatives |
| 04/19/2000 | CN1051550C 4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopntene-1-methanol succinate as antiviral agent |
| 04/19/2000 | CN1051549C 2-aminoalkyl-5-aminoalkylamino substituted isoquinoindazole-6-(2h)-ones, pharmaceutical composition and prepn. thereof |
| 04/19/2000 | CN1051548C Heterobicyclic derivatives, pharmaceutical compositions contg. same, mfg. method and use thereof |
| 04/19/2000 | CN1051547C Beta-lactams derivative and its prepn.and use |
| 04/19/2000 | CN1051546C Novel 1,1-bis(heteroazolyl) alkane derivatives and their use as neuroprotective agents |
| 04/19/2000 | CN1051545C 5-(aryloxymethyl) oxazolines, process for prepn. thereof and pharmaceutical compositions contg. same |
| 04/19/2000 | CN1051466C External use medicine for seborrheic baldness |
| 04/19/2000 | CN1051465C External use medicine for seborrheic baldness |
| 04/19/2000 | CN1051464C Oral medicine for curing seborrheic baldness |
| 04/19/2000 | CN1051459C Health-care medicament for rehabilitating function of human body |
| 04/19/2000 | CN1051454C Vagina anticoncipiens contg. delta-gluconolactone |
| 04/19/2000 | CN1051453C Compositions of clindamycin and benzoyl peroxide for acne treatment |
| 04/19/2000 | CN1051452C Application of 3-substituted aryl oxidized indole compounds |
| 04/19/2000 | CN1051451C Anti-AIDS-virus drug composition |
| 04/19/2000 | CA2282908A1 Purification and crystallization process for riboflavin |
| 04/18/2000 | USRE36665 Polyoxypropylene/polyoxyethylene copolymers with improved biological activity |
| 04/18/2000 | US6051731 O-or S-substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
| 04/18/2000 | US6051718 A phosphodiesterase enzyme inhibitor and a cytokine antagonist for treating allergic, atopic and inflammatory diseases inflammatory diseases |
| 04/18/2000 | US6051716 Antimicrobial agents |
| 04/18/2000 | US6051713 Substituted aryl or heteroarylamides having retinoid-like biological activity |
| 04/18/2000 | US6051712 Piperidine derivatives having renin inhibiting activity |
| 04/18/2000 | US6051711 Acid hydrolysis in the presence of a c1-c4 alkanol to obtain a crystalline salt of swainsonine |
| 04/18/2000 | US6051703 Broad spectrum antibiotic |
| 04/18/2000 | US6051701 Sulfated hyaluronic acid esters |
| 04/18/2000 | US6051688 Amino acid sequence for polypeptide of at least 6 contiguous amino acids; for diagnosis and treatment of nervous system disorders; anticonvulsants; antiischemic/antihypoxic agents; antiepileptic agents; alzheimer's/parkinson's diseases |
| 04/18/2000 | US6051684 Contacting a composition containing amyloid precursor protein with di- or tripeptide analog causing a decrease in a-beta-peptide or an increase in alpha-s-amyloid precursor protein |
| 04/18/2000 | US6051611 Polymeric quaternary ammonium compounds and their use as ophthalmic antimicrobias |
| 04/18/2000 | US6051610 Compounds useful as neuroprotectants, anticonvulsants, anxiolytics, analgesics, muscle relaxants or adjuvants to general anesthetics |
| 04/18/2000 | US6051608 Solid compositions suitable for oral administration comprising L-carnitine or alkanoyl-L-carnitine magnesium fumarate |
| 04/18/2000 | US6051605 Treating psychosis and schizophrenia using a compound that is an antagonist of dopamine d4 receptors |
| 04/18/2000 | US6051604 Compositions comprising bismuth and one or more antimicrobials for prevention and treatment of gastrointestinal disorder caused or mediated by one or more intestinal helminths |
| 04/18/2000 | US6051603 Novel spermicidal compounds which are organometallic cyclopentadienyl metal complexes, particularly vanadium iv complexes |
| 04/18/2000 | US6051602 Methods for regulating skin appearance |
| 04/18/2000 | US6051601 Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene B4 (LTB4) antagonists |
| 04/18/2000 | US6051600 Lipid carrier taxane derivative-containing pharmaceutical compositions useful in treatement of cancers |
| 04/18/2000 | US6051599 Endothelin receptor antagonists |
| 04/18/2000 | US6051598 Treating a patient having sphingolipidosis by reducing glycosphingolipid synthesis |
| 04/18/2000 | US6051597 Indolylquinones as antidiabetic agents |
| 04/18/2000 | US6051594 Orally administering a formulation of the vasodilator phentolamine to the blood circulation |